Alkermes (ALKS) EBIT (2010 - 2026)

Alkermes (ALKS) has 17 years of EBIT data on file, last reported at -$48.3 million in Q1 2026.

• EBIT for Q1 2026 came in at -$48.3 million, down 450.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $191.9 million (down 50.94% YoY), and the FY2025 annual result was $254.0 million, down 39.63% from the prior year.
• EBIT retreated to -$48.3 million in Q1 2026 per ALKS's latest filing, from $58.1 million in the prior quarter.
• Over five years, EBIT peaked at $281.3 million in Q2 2023 and troughed at -$306.8 million in Q4 2023.
• A 5-year average of $39.6 million and a median of $58.1 million in 2025 frame the typical range for EBIT.
• The sharpest annual moves came in 2022 and 2023: EBIT sank 879.39% in 2022, then soared 916.29% in 2023.
• A 5-year view of EBIT shows it stood at $115.6 million in 2022, then sank by 365.41% to -$306.8 million in 2023, then surged by 153.03% to $162.7 million in 2024, then sank by 64.29% to $58.1 million in 2025, then sank by 183.09% to -$48.3 million in 2026.
• Business Quant data shows ALKS's EBIT at -$48.3 million in Q1 2026, $58.1 million in Q4 2025, and $89.1 million in Q3 2025.